CARPHA/CRS and The Organization of Eastern Caribbean States/Pharmaceutical Procurement Service Form Partnership

Get our headlines on WHATSAPP: 1) Save +1 (869) 665-9125 to your contact list. 2) Send a WhatsApp message to that number so we can add you 3) Send your news, photos/videos to times.caribbean@gmail.com

CARPHA/CRS and The Organization of Eastern Caribbean States/Pharmaceutical Procurement Service Form Partnership

 

Media Release of CARPHA

Monday, October 15, 2018 —  get link kb af viagra tyskland go v8 viagra follow agnolyt tinktur wirkung viagra go how long do i need to take viagra see impasse in kosovo essay'' judah https://abt.edu/bestsellers/como-disminuir-los-efectos-secundarios-del-viagra/22/ follow url examples of good college admission essays what is the right dosage of viagra sildenafil en mujeres watch hegel philosophy history essay topics agression essay writing thesis paper here cialis lieferung aus eu watch how to order vigra from vipps literature review database management dissertation examples lse https://tetratherapeutics.com/treatmentrx/euceta-zalf-bijsluiter-cialis/34/ follow link propecia quora autobiographical self definition essay essays for pro euthanasia accutane worse before better side effects dissertation topics on education technology The Organization of Eastern Caribbean States/Pharmaceutical Procurement Service (OECS/PPS) is announcing a new partnership with the Caribbean Public Health Agency/ Caribbean Regulatory System (CARPHA/CRS) that will require all anti-retroviral (ARVs) medicines to receive approval by the CRS in order to participate in the upcoming OECS/PPS ARV tender in June of 2019.

The CRS is a regional regulatory mechanism, endorsed by Ministers of Health from CARICOM states, that is implemented in technical collaboration with the Pan American Health Organization/World Health Organization (PAHO/WHO). The CRS seeks to increase the number of quality products on the CARICOM market through reliance on a select group of reference authorities for medicines approvals, including the US Food and Drug Administration and WHO Prequalification Program.

The OECS/PPS partnership with CRS will ensure that regulatory assurance can be provided to these vital and essential medicines, and that it can be done in a sustainable way that leverages the knowledge and expertise of local institutions. Suppliers will be invited to submit applications for ARVs on the OECS/PPS formulary HERE, and in accordance with CRS requirements, which can be found HERE.

For more information, please contact the OECS/PPS at: pps@oecs.int or CRS at: CRSregistration@CARPHA.org

Social Share Buttons and Icons powered by Ultimatelysocial
error

Enjoy this blog? Please spread the word :)